KRAS and cancer: However, the cytotoxicity of BRAF and CRAF siRNAs is enhanced when ATG7 is knocked down, suggesting that KRAS-driven metabolic alterations in cancer cells make them particularly dependent on the autophagy pathway as a survival mechanism when the RAF/MAPK pathway is acutely inhibited [238].